Plasmodium falciparumProtein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya
Open Access
- 15 April 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 212 (9) , 1429-1438
Abstract
Background. Immunoglobulin G antibodies (Abs) to Plasmodium falciparum antigens have been associated with naturally acquired immunity to symptomatic malaria. Methods. We probed protein microarrays covering 824 unique P. falciparum protein features with plasma from residents of a community in Kenya monitored for 12 weeks for (re)infection and symptomatic malaria after administration of antimalarial drugs. P. falciparum proteins recognized by Abs from 88 children (aged 1–14 years) and 86 adults (aged ≥18 years), measured at the beginning of the observation period, were ranked by Ab signal intensity. Results. Abs from immune adults reacted with a total 163 of 824 P. falciparum proteins. Children gradually acquired Abs to the full repertoire of antigens recognized by adults. Abs to some antigens showed high seroconversion rates, reaching maximal levels early in childhood, whereas others did not reach adult levels until adolescence. No correlation between Ab signal intensity and time to (re)infection was observed. In contrast, Ab levels to 106 antigens were significantly higher in children who were protected from symptomatic malaria compared with those who were not. Abs to antigens predictive of protection included P. falciparum erythrocyte membrane protein 1, merozoite surface protein (MSP) 10, MSP2, liver-stage antigen 3, PF70, MSP7, and Plasmodium helical interspersed subtelomeric domain protein. Conclusions. Protein microarrays may be useful in the search for malaria antigens associated with protective immunity.Keywords
Funding Information
- National Institutes of Health (AI098511, AI043906, AI089686, AI095916, AI095192)
This publication has 37 references indexed in Scilit:
- Wheat Germ Cell-Free System-Based Production of Malaria Proteins for Discovery of Novel Vaccine CandidatesInfection and Immunity, 2008
- A combined transcriptome and proteome survey of malaria parasite liver stagesProceedings of the National Academy of Sciences, 2008
- Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniquesBioinformatics, 2006
- Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposureProceedings of the National Academy of Sciences, 2005
- Testing association of a pathway with survival using gene expression dataBioinformatics, 2005
- Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103Molecular and Biochemical Parasitology, 2004
- A proteomic view of the Plasmodium falciparum life cycleNature, 2002
- A Recombinant Blood‐Stage Malaria Vaccine ReducesPlasmodium falciparumDensity and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New GuineaThe Journal of Infectious Diseases, 2002
- A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changesBioinformatics, 2001
- Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3Nature Medicine, 2000